...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Complications after endovascular repair of acute symptomatic and chronic expanding Stanford type B aortic dissections.
【24h】

Complications after endovascular repair of acute symptomatic and chronic expanding Stanford type B aortic dissections.

机译:急性症状和慢性扩展的斯坦福B型主动脉夹层血管内修复后的并发症。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To outline the complications after endovascular repair in patients with acute symptomatic and chronic expanding Stanford type B aortic dissections. METHODS: Between 1997 and 2004, of 125 patients with acute and chronic aortic type B dissections, 88 were treated conservatively. Thirty-seven patients (29 male, mean age 58 years, range 30-82 years) underwent endovascular repair (30%) using 44 stent grafts of 3 different designs: Excluder (W. L. Gore & Associates, Inc, Flagstaff, Ariz), Talent (Medtronic Vascular, Santa Rosa, Calif), and Endofit (Endomed, Inc, Phoenix, Ariz). Indications for treatment were acute symptomatic type B dissection in 15 patients, chronic expanding aortic dissection greater than 55 mm in 14, rupture in 3, and simultaneous type A repair in 5 patients. Twenty-two operations were performed on an emergency basis. Patient characteristics, procedural variables, outcome, and complications were prospectively recorded. All patients underwent follow-up by computed tomography before discharge, at 6 and 12 months, and annually thereafter (mean follow-up: 24 months). RESULTS: Correct deployment was achieved in 97% of cases. There were no instances of primary conversion, paraplegia, or stroke. Complete false lumen thrombosis was observed in 11 patients (44%). Perioperative complication rate was 22%. Thirty-day mortality rate in acute and chronic dissections was 19% and 0%, respectively. Freedom from aortic reintervention was 81%, 73%, and 68%, freedom from late rupture was 97%, 90%, and 80%, and overall success rate was 76%, 65%, and 57% at 1, 2, and 5 years, respectively. Results for patients with chronic dissections are significantly (P = .038) better than results in those with acute dissections. CONCLUSIONS: Despite the minimally invasive approach, the complication and mortality rates for endovascular therapy of aortic dissections are still high. Frank reporting of these sequelae is if great importance to clarify the recent limitations of the method.
机译:目的:概述急性症状性和慢性扩张性斯坦福B型主动脉夹层患者血管内修复后的并发症。方法:1997年至2004年,在125例急,慢性B型主动脉夹层患者中,保守治疗88例。三十七名患者(29名男性,平均年龄58岁,范围30-82岁)接受了44种3种不同设计的支架移植物的血管内修复(30%):排骨器(WL Gore&Associates,Inc,弗拉格斯塔夫,亚利桑那州),才华横溢(Medtronic Vascular,加利福尼亚州圣罗莎)和Endofit(Endomed,Inc,凤凰城,亚利桑那州)。治疗的适应症有15例急性症状性B型夹层,14例大于55毫米的慢性主动脉夹层破裂,3例破裂,5例同时进行A型修复。在紧急情况下进行了22项操作。前瞻性地记录患者的特征,程序变量,结局和并发症。所有患者在出院前,6个月和12个月以及之后每年进行一次计算机断层扫描(平均随访:24个月)。结果:在97%的情况下,部署正确。没有原发性转化,截瘫或中风的病例。在11名患者中观察到完全的假管腔血栓形成(44%)。围手术期并发症发生率为22%。急性和慢性解剖的30天死亡率分别为19%和0%。主动脉再介入的自由度为81%,73%和68%,晚期破裂的自由度为97%,90%和80%,1、2和3时的总成功率为76%,65%和57%。 5年了。慢性夹层患者的结果明显好于急性夹层患者(P = .038)。结论:尽管采用微创方法,但主动脉夹层血管内治疗的并发症和死亡率仍然很高。对于这些后遗症的坦率报道对于阐明该方法的近期局限性非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号